Skip to main content

Ovid Therapeutics Inc.

OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636651

No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Ovid Therapeutics Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of OVID: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders7781+4
Shares51.7M50.1M−1.55M (−3.0%)
Value$166.3M$152.8M−$13.5M (−8.1%)

New holders (12)

Institutions that held Ovid Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to OVID in Q1 2024
InstitutionSharesValue% of portfolio
Prosight Management, LP983,200$3.00M0.83%
Wellington Management Group LLP222,893$679.8K0.00%
Millennium Management LLC145,965$445.2K0.00%
Two Sigma Investments, LP40,669$124.0K0.00%
Prelude Capital Management, LLC25,555$77.9K0.01%
Occudo Quantitative Strategies LP14,086$43.0K0.01%
Simplex Trading, LLC1,233$3.00K0.00%
Qube Research & Technologies Ltd54$1650.00%
Frazier Financial Advisors, LLC10$310.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC10$300.00%
Sound Income Strategies, LLC6$180.00%
CWM, LLC5$00.00%

Sold out (8)

Institutions that held Ovid Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of OVID in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Vestal Point Capital, LP85,429$275.1K
Mirae Asset Global Investments Co., Ltd.33,996$109.5K
Virtu Financial LLC24,264$78.0K
Susquehanna International Group, LLP22,220$71.5K
State Board of Administration of Florida Retirement System17,230$55.5K
Newman Dignan & Sheerar, Inc.16,522$53.2K
Cutler Group LP2,100$6.00K
The PNC Financial Services Group, Inc.10$32